Get started
Author

Nuria Mancheño

Observed names: N. Mancheno, N. Mancheño
ORCID: 0000-0003-1110-1758
Observed ORCID: 0000-0003-1110-1758
OpenAlex ID: A5109394325
Assessment of a New ROS1 Immunohistochemistry Clone (SP384) for the Identification of ROS1 Rearrangements in Patients with Non–Small Cell Lung Carcinoma: the ROSING Study
2019 · Esther Conde, Susana Hernandez, et al. · Journal of Thoracic Oncology · 74
Molecular diagnosis in non-small-cell lung cancer: expert opinion on ALK and ROS1 testing
2021 · Esther Conde, Federico Rojo, et al. · Journal of Clinical Pathology · 47
Netrin-1 receptor antibodies in thymoma-associated neuromyotonia with myasthenia gravis
2017 · Estefanía Torres-Vega, Nuria Mancheño, et al. · Neurology · 37
PDF
Salvage therapy with topical posaconazole in lung transplant recipients with invasive Scedosporium infection
2017 · Amparo Solé, Ana A. García-Robles, et al. · American Journal of Transplantation · 27
Development, Implementation and Assessment of Molecular Diagnostics by Next Generation Sequencing in Personalized Treatment of Cancer: Experience of a Public Reference Healthcare Hospital
2019 · Javier Simarro, Rosa Murria, et al. · Cancers · 21
PDF
Impact of Molecular Testing Using Next-Generation Sequencing in the Clinical Management of Patients with Non-Small Cell Lung Cancer in a Public Healthcare Hospital
2023 · Javier Simarro, Gema Pérez-Simó, et al. · Cancers · 18
PDF
Increased Tumor Growth Rate and Mesenchymal Properties of NSCLC-Patient-Derived Xenograft Models during Serial Transplantation
2021 · José Miguel Pardo-Sánchez, Nuria Mancheño, et al. · Cancers · 16
PDF
RET Fusion Testing in Patients With NSCLC: The RETING Study
2024 · Esther Conde, Susana Hernandez, et al. · JTO Clinical and Research Reports · 9
PDF
Early radiological response as predictor of overall survival in non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor mutations
2018 · Carmen Salvador-Coloma, David Lorente, et al. · Journal of Thoracic Disease · 8
PDF
Technical Validation and Clinical Implications of Ultrasensitive PCR Approaches for EGFR-Thr790Met Mutation Detection in Pretreatment FFPE Samples and in Liquid Biopsies from Non-Small Cell Lung Cancer Patients
2022 · Javier Simarro, Gema Pérez-Simó, et al. · International Journal of Molecular Sciences · 6
PDF
Cardiac phenotype in glycogen storage disease type XV: a rare cardiomyopathy to bear in mind
2020 · Nuria Mancheño, Aitana Braza-Boïls, et al. · Revista Española de Cardiología (English Edition) · 5
Utility of Next-Generation Sequencing in the Reconstruction of Clonal Architecture in a Patient with an EGFR Mutated Advanced Non-Small Cell Lung Cancer: A Case Report
2022 · Javier Simarro, Gema Pérez-Simó, et al. · Diagnostics · 4
PDF
Histiocitosis pulmonar: más allá de la histiocitosis de células de Langerhans relacionada con el tabaco
2019 · C. Trejo Gallego, J. Bueno, et al. · Radiología · 4
Fenotipo cardiológico de la glucogenosis tipo XV: una miocardiopatía muy infrecuente a tener en cuenta
2020 · Nuria Mancheño, Aitana Braza-Boïls, et al. · Revista Española de Cardiología · 3
Pulmonary histiocytosis: Beyond Langerhans cell histiocytosis related to smoking
2019 · C. Trejo Gallego, J. Bueno, et al. · Radiología (English Edition) · 3
Multimodality management of a locally advanced primary oesophageal melanoma with radical surgery and adjuvant chemoimmunoradiotherapy
2010 · Roberto Díaz, Pedro Moral, et al. · Clinical & Translational Oncology · 2
Characterization of the Thermal Properties of Healthy vs Infarcted Ventricular Tissue
2025 · Maite Izquierdo, Juan J. Pérez, et al. · JACC. Clinical electrophysiology · 1
MA14.02 RET Fusion Testing in Advanced Non-Small Cell Lung Carcinoma Patients: the RETING Study
2021 · E. Conde, S. Hernandez, et al. · Journal of Thoracic Oncology · 1
PDF
Development of primary human NSCLC patient derived xenograft and organoids models as a precision approach to tumor treatment
2018 · O.J. Juan Vidal, C. Gandia, et al. · Annals of Oncology · 1
Prognostic factors in oligometastatic non-small-cell lung cancer (OM-NSCLC) patients treated with ablative therapy.
2018 · Juan Antonio Mendez, Domingo Benjamín, et al. · Journal of Clinical Oncology · 1
Pathologists’ experience and routine practice in high-volume lung transplant centers: An international survey
2025 · Fiorella Calabrese, David M. Hwang, et al. · JHLT Open
PDF
Correction: Pardo-Sánchez et al. Increased Tumor Growth Rate and Mesenchymal Properties of NSCLC-Patient-Derived Xenograft Models during Serial Transplantation. Cancers 2021, 13, 2980
2021 · José Miguel Pardo-Sánchez, Nuria Mancheño, et al. · Cancers
PDF
Pretreatment T790M mutation detection by ultrasensitive PCR assay as predictor of efficacy in non-small lung cancer (NSCLC) patients treated with 1st or 2nd generation EGFR tyrosine kinase inhibitors (TKIs)
2019 · O.J. Juan Vidal, J. Simarro, et al. · Annals of Oncology
P1.09-09 Evaluation of a Novel ROS1 Immunohistochemistry Clone (SP384) for the Identification of ROS1 Rearrangements in NSCLC Patients
2018 · E. Conde, S. Hernandez, et al. · Journal of Thoracic Oncology
PDF
137PD Prognostic factors in oligometastatic non-small-cell lung cancer (OM-NSCLC)
2018 · O. Juan, J.A. Méndez, et al. · Journal of Thoracic Oncology
PDF
Works count: 26
Citation count: 288
H-index: 8
I10-index: 7
Year
Topic
Type